Monograph Details
|
|
Dermatological Disorders
> Skin infections (topicals)
|
|
XOLEGEL |
| Manufacturer |
|
Barrier Therapeutics |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Azole. |
| Generic Name |
|
Ketoconazole 2%; topical gel (anhydrous). |
| Indications |
|
Topical treatment of seborrheic dermatitis in immunocompetent patients. |
| Children |
|
Not recommended. |
| Adults |
|
Apply a thin layer to affected area(s) once daily for 2 weeks. Wash hands before and after use. Do not wash treated areas for at least 3 hours after application. Wait at least 20 mins before applying cosmetics, sunscreen, etc. |
| Precautions |
|
Avoid eyes, lips, mucous membranes. If irritation occurs or if disease worsens, then the use of the medication should be discontinued. Product is flammable (avoid open flames, smoking while applying). Pregnancy (Cat.C). Nursing mothers. |
| Adverse Reactions |
|
Application site burning, headache. |
| How Supplied |
Gel—15g
Xolegel Duo—1 kit (15g gel + 4oz Xolex shampoo [zinc pyrithione 1%]); or (15g gel + 1.7oz Head & Shoulders shampoo [zinc pyrithione 1%]) |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
